BMC
GILD icon

Bear Mountain Capital’s Gilead Sciences GILD Stock Holding History

Bear Mountain Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260 Hold
2
– – ﹤0.01% 185
2026
Q1 		$272 Hold
2
– – ﹤0.01% 166
2025
Q4 		$243 Hold
2
– – ﹤0.01% 172
2025
Q3 		$248 Buy
+2
New +$227 ﹤0.01% 253
2025
Q2 		– Sell
-10
Closed -$1.06K – 238
2025
Q1 		$1.06K Buy
+10
New +$1.03K ﹤0.01% 178

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bear Mountain Capital's GILD Position: Q2 2026 in Review

Bear Mountain Capital held its Gilead Sciences (GILD) position steady in Q2 2026 at 2 shares worth $260. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Bear Mountain Capital first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.06K in Q1 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bear Mountain Capital held 2 shares of Gilead Sciences worth $260 as of Q2 2026.
  • Bear Mountain Capital left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #185 holding.
  • Bear Mountain Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Bear Mountain Capital's Gilead Sciences position peaked at $1.06K in Q1 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.